A selective inhibitor of B-RafV600E mutant melanoma cell proliferation (EC50 = 4 nM) with little activity against wild-type B-Raf or a panel of 100 other kinases (IC50s = 900 nM); decreases phosphorylation of the B-Raf substrate MEK at oral doses of 6 mg/kg in human melanoma xenograft models